IVF at 38 With Low AMH and Low Sperm Motility: Plan for Both Partners

AMH and antral follicle count can help anticipate how the ovaries may respond to stimulation, but neither measures egg quality directly or guarantees that pregnancy cannot occur. At 38, age is independently important for counselling about reproductive potential. Ask how the available measurements relate to past stimulation response, if there has been a cycle before. A low AMH result should not be used as a reason to sell unproven supplements or an expensive 'ovarian rejuvenation' programme. Equally, a normal-looking scan does not erase age-related considerations.

Total motile sperm depends on concentration, semen volume and the movement pattern, not just one highlighted percentage. Repeat semen analysis may be helpful when the result is unexpected or the sample was compromised. A qualified clinician can consider male medical history, medicines, examination and targeted investigations when indicated. The important question is whether a prepared sample supports IUI, whether conventional IVF is appropriate or whether ICSI has a clear fertilisation indication. A male-factor concern does not automatically mean expensive tests such as sperm DNA fragmentation are required.

Depending on the complete workup, doctors may discuss an IVF cycle, with or without ICSI, and whether another approach has a plausible role. The proposed egg-yield estimate is not a promise, and no one can know exactly how many mature eggs or embryos will result before the process occurs. Review the case for any repeat stimulation, embryo freezing and transfer timing. Age-related urgency should encourage a timely, documented decision, not pressure to purchase unvalidated add-ons or skip preconception safety checks. A second opinion may help clarify conflicting recommendations.

An apparent 'single cycle' price can hide medicines, monitoring, ICSI, freezing, storage, later transfer and repeat attempts. Ask which costs are payable even if few or no eggs are obtained. If home-supported monitoring or injections are relevant, confirm actual local availability and who oversees results. The couple may also need to plan work leave or travel for essential scans and procedures. Having a written contingency plan can reduce confusion when results differ from estimates, while recognising that no provider can guarantee fertilisation or live birth.

HomeIVF describes a doctor-led, home-supported fertility care approach, not a technique for performing IVF in a bedroom or from a mail-order kit. Where actually available, teleconsultation, selected clinician-ordered blood collection and appropriately supervised injection support may reduce unnecessary clinic travel. The treating team still decides when ultrasound imaging or in-person assessment is essential. Egg retrieval, embryology, sperm and egg handling, embryo freezing and embryo transfer stay in suitable licensed or registered facilities. Teleconsultation may help both partners review reports together; safety-driven scans and all embryology and transfer steps remain in a clinical setting. Before paying, ask which services are actually offered at your location, who provides them, where procedures take place, and whom you contact if symptoms require urgent assessment.

A useful consultation should end with decisions, not a generic promise. Bring AMH and AFC reports, previous response records, two semen analyses and complete reproductive histories. Ask the clinician to explain whether IVF with or without ICSI addresses the actual findings and how age and likely ovarian response affect the timing and budget. Clarify the treatment choices if the first plan does not work, which finding would change the recommendation, and the point at which another specialist should be involved. If a test or add-on is suggested, request its purpose, limitations and out-of-pocket price. Consent should cover medicines, sample handling, facility procedures and the communication plan. It is reasonable to request a written summary; a second opinion can be valuable when results and recommendations do not seem to match.

Example decision, not a prediction: A couple is told either to focus only on low AMH or only on sperm motility. They seek a combined review and receive a plan addressing response uncertainty, laboratory fertilisation options and clear prices for potential freezing or later transfer. The next step is to compare the available evidence, personal circumstances and practical constraints with a qualified clinician. Two people asking about the same headline condition may receive different recommendations because age, prior history, laboratory findings and safety needs are different. No blood test, embryo label or quoted package can guarantee a live birth. This example is for understanding the questions, not for self-prescribing medication or skipping clinical review.